Liebe VCS Mitglieder,
auch Ihr könnt einen Beitrag zur Erforschung des Corona-Virus leisten. Die ETH führt zur Zeit eine Studie durch, bei der Blutproben von gesunden, infizierten und genesenen ETH Studierenden und Mitarbeitenden analysiert werden, um so Informationen über die Seroprävalenz und die Immunantwort bei einer Infektion zu sammeln. Wir würden uns freuen, wenn Ihr die Zeit findet an dieser Studie teilzunehmen. Die Anmeldung erfolgt hier.
Bleibt gesund!
Eure VCS
Den originale Text zur Studie folgt:
Dear Student Associations,
ETH Zurich is currently performing a longitudinal research study to investigate the immune response in people following a COVID-19 infection. ETH students are eligible to participate. Enrollment (here) is possible until Friday, May 8, 2020.
We would be grateful if you could inform your peers about the «CoV-ETH Study» and the opportunity to participate.
The study involves blood drawings in currently healthy individuals (ETH students and employees) with either past or possible future COVID-19 infection and filling out a questionnaire. The primary objective of the study is to determine both the seroprevalence as well as the titer of serum antibodies targeting SARS-CoV-2 antigens in patients with asymptomatic versus clinically apparent infections during a study period of one year. The study also hopes to inform on the role of different immune cells (B and T lymphocytes) in fighting a COVID-19 infection and to explore the dynamics of serum antibodies titers against SARS-CoV-2. Furthermore, the study will investigate if potential T-cell and antibody cross-reactivities to SARS-CoV-2 and common cold coronavirus infections affect the immune response to these respiratory infections.
Detailed information about the study can be obtained at:
https://ethz.ch/services/en/news-and-events/solidarity/cov-eth-study/cov-eth-detailed-information.html
Many thanks for your support for this important endeavor!
With kind regards,
Susanne Ulbrich
Markus Stoffel
Jörg Goldhahn
